Comparative cytotoxicity of fourteen trivalent and pentavalent arsenic species determined using real-time cell sensing

Journal of Environmental Sciences (China)

Volumn 49, Issue , 2016, Pages 113-124

  Moe, Birget ^a,b   Peng, Hanyong ^a   Lu, Xiufen ^a   Chen, Baowei ^a,c   Chen, Lydia W L ^a,d,e   Gabos, Stephan ^a   Li, Xing Fang ^a   Le, X Chris ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c SUN YAT SEN UNIVERSITY   (China)

^d BROCK UNIVERSITY   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Arsenic species; Methylarsenicals; Phenylarsenicals; Real time sensing; Thio arsenicals; Toxicity

Indexed keywords

ARSENIC; CELL CULTURE; CYTOTOXICITY; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; TOXICITY;

ARSENIC SPECIES; METHYLARSENICALS; PHENYLARSENICALS; REAL TIME SENSING; THIO-ARSENICALS;

CELLS;

ARSENIC; CELL ORGANELLE; COMPARATIVE STUDY; EXPERIMENTAL STUDY; INDUCTIVELY COUPLED PLASMA METHOD; REAL TIME; TOXICITY; TOXICITY TEST;

ARSENIC; ARSENOSOBENZENE; CACODYLIC ACID; DANGEROUS GOODS; DIMETHYLARSINOUS ACID; METHANEARSONIC ACID; ORGANOARSENIC DERIVATIVE;

ANALOGS AND DERIVATIVES; DANGEROUS GOODS; TOXICITY; TOXICITY TESTING;

ARSENIC; ARSENICALS; CACODYLIC ACID; HAZARDOUS SUBSTANCES; TOXICITY TESTS;

EID: 85006699507     PISSN: 10010742     EISSN: 18787320     Source Type: Journal    
DOI: 10.1016/j.jes.2016.10.004     Document Type: Article

References (85)

1. 14C] arsanilic acid in pigs and chickens. J. Agric. Food Chem. 39 (1991), 146–149.
2. V in cultured human lung cells. J. Toxicol. 2011 (2011), 1–9, 373141, 10.1155/2011/373141.
3. Boyd, J.M., Huang, L., Xie, L., Moe, B., Gabos, S., Li, X.F., A cell-microelectronic sensing technique for profiling cytotoxicity of chemicals. Anal. Chim. Acta 615 (2008), 80–87.
4. Challenger, F., Biological methylation. Chem. Rev. 36 (1945), 315–361.
5. Charoensuk, V., Gati, W.P., Weinfeld, M., Le, X.C., Differential cytotoxic effects of arsenic compounds in human acute promyelocytic leukemia cells. Toxicol. Appl. Pharmacol. 239 (2009), 64–70.
6. Chen, W.R., Huang, C.H., Surface adsorption of organoarsenic roxarsone and arsanilic acid on iron and aluminum oxides. J. Hazard. Mater. 227-228 (2012), 378–385.
7. Chen, B., Arnold, L.L., Cohen, S.M., Thomas, D.J., Le, X.C., Mouse arsenic (+ 3 oxidation state) methyltransferase genotype affects metabolism and tissue dosimetry of arsenicals after arsenite administration in drinking water. Toxicol. Sci. 124 (2011), 320–326.
8. Chen, B., Liu, Q., Popowich, A., Shen, S., Yan, X., Zhang, Q., et al. Therapeutic and analytical applications of arsenic binding to proteins. Metallomics 7 (2015), 39–55.
9. Chen, B., Lu, X., Arnold, L.L., Cohen, S.M., Le, X.C., Identification of methylated dithioarsenicals in the urine of rats fed with sodium arsenite. Chem. Res. Toxicol. 29 (2016), 1480–1487.
10. Chiang, H.C., Tsou, T.C., Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells. Toxicol. In Vitro 23 (2009), 897–905.
11. Cohen, S.M., Chowdhury, A., Arnold, L.L., Inorganic arsenic: a non-genotoxic carcinogen. J. Environ. Sci. 49 (2016), 28–37.
12. Cullen, W.R., Chemical mechanism of arsenic biomethylation. Chem. Res. Toxicol. 27 (2014), 457–461.
13. Cullen, W.R., Reimer, K.J., Arsenic speciation in the environment. Chem. Rev. 89 (1989), 713–764.
14. Cullen, W.R., McBride, B.C., Manji, H., Pickett, A.W., Reglinski, J., The metabolism of methylarsine oxide and sulfide. Appl. Organomet. Chem. 3 (1989), 71–78.
15. Cullen, W.R., Liu, Q., Lu, X., McKnight-Whitford, A., Peng, H., Popowich, A., et al. Methylated and thiolated arsenic species for environmental and health research – a review on synthesis and characterization. J. Environ. Sci. 49 (2016), 7–27.
16. Currier, J.M., Douillet, C., Drobna, Z., Styblo, M., Oxidation state specific analysis of arsenic species in tissues of wild-type and arsenic (+ 3 oxidation state) methyltransferase-knockout mice. J. Environ. Sci. 49 (2016), 104–112.
17. Desheng, Q., Niya, Z., Effect of arsanilic acid on performance and residual of arsenic in tissue of Japanese laying quail. Poult. Sci. 85 (2006), 2097–2100.
18. Dheeman, D.S., Packianathan, C., Pillai, J.K., Rosen, B.P., Pathway of human AS3MT arsenic methylation. Chem. Res. Toxicol. 27 (2014), 1979–1989.
19. Dopp, E., Hartmann, L.M., Florea, A.M., von Recklinghausen, U., Pieper, R., Shokouhi, B., et al. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. Toxicol. Appl. Pharmacol. 201 (2004), 156–165.
20. Dopp, E., Hartmann, L.M., von Recklinghausen, U., Florea, A.M., Rabieh, S., Zimmermann, U., et al. Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fibroblasts and hepatoma cells. Toxicol. Sci. 87 (2005), 46–56.
21. Dopp, E., von Recklinghausen, U., Hartmann, L.M., Stueckradt, I., Pollok, I., Rabieh, S., et al. Subcellular distribution of inorganic and methylated arsenic compounds in human urothelial cells and human hepatocytes. Drug Metab. Dispos. 36 (2008), 971–979.
22. Dopp, E., von Recklinghausen, U., Diaz-Bone, R., Hirner, A.V., Rettenmeier, A.W., Cellular uptake, subcellular distribution and toxicity of arsenic compounds in methylating and non-methylating cells. Environ. Res. 110 (2010), 435–442.
23. Drobna, Z., Waters, S.B., Devesa, V., Harmon, A.W., Thomas, D.J., Styblo, M., Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+ 3 oxidation state)-methyltransferase. Toxicol. Appl. Pharmacol. 207 (2005), 147–159.
24. Drobna, Z., Naranmandura, H., Kubachka, K.M., Edwards, B.C., Herbin-Davis, K., Styblo, M., et al. Disruption of the arsenic (+ 3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem. Res. Toxicol. 22 (2009), 1713–1720.
25. Gong, Z., Lu, X., Cullen, W.R., Le, X.C., Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J. Anal. At. Spectrom. 16 (2001), 1409–1413.
26. Hansen, H.R., Raab, A., Jaspars, M., Milne, B.F., Feldmann, J., Sulfur-containing arsenical mistaken for dimethylarsinous acid [DMA(III)] and identified as a natural metabolite in urine: major implications for studies on arsenic metabolism and toxicity. Chem. Res. Toxicol. 17 (2004), 1086–1091.
27. Hayakawa, T., Kobayashi, Y., Cui, X., Hirano, S., A new metabolic pathway of arsenite: arsenic–glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol. 79 (2005), 183–191.
28. Hirano, S., Cui, X., Li, S., Kanno, S., Kobayashi, Y., Hayakawa, T., et al. Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells. Arch. Toxicol. 77 (2003), 305–312.
29. Hughes, M.F., Beck, B.D., Chen, Y., Lewis, A.S., Thomas, D.J., Arsenic exposure and toxicology: a historical perspective. Toxicol. Sci. 123 (2011), 305–332.
30. IARC (International Agency for Research on Cancer), IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100C: Arsenic, Metals, Fibres, and Dusts. 2012, IARC, Lyon, France.
31. Jones, F.T., A broad view of arsenic. Poult. Sci. 86 (2007), 2–14.
32. Judson, R.S., Houck, K.A., Kavlock, R.J., Knudsen, T.B., Martin, M.T., Mortensen, H.M., et al. In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project. Environ. Health Perspect. 118 (2010), 485–492.
33. Kang, S.J., Jeong, S.H., Kim, E.J., Park, Y.I., Park, S.W., Shin, H.S., et al. Toxic effects of methylmercury, arsanilic acid and danofloxacin on the differentiation of mouse embryonic stem cells into neural cells. J. Vet. Sci. 15:1 (2014), 61–71.
34. Kazi, T.G., Shah, A.Q., Afridi, H.I., Shah, N.A., Arain, M.B., Hazardous impact of organic arsenical compounds in chicken feed on different tissues of broiler chicken and manure. Ecotoxicol. Environ. Saf. 87 (2013), 120–123.
35. Le, X.C., Lu, X., Ma, M., Cullen, W.R., Aposhian, H.V., Zheng, B., Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 72 (2000), 5172–5177.
36. Leermakers, M., Baeyens, W., De Gieter, M., Smedts, B., Meert, C., De Bisschop, H.C., et al. Toxic arsenic compounds in environmental samples: speciation and validation. TrAC Trends Anal. Chem. 25 (2006), 1–10.
37. Leffers, L., Unterberg, M., Bartel, M., Hoppe, C., Pieper, I., Stertmann, J., et al. In vitro toxicological characterisation of the S-containing arsenic metabolites thio-dimethylarsinic acid and dimethylarsinic glutathione. Toxicology 305 (2013), 109–119.
38. Lin, S., Cullen, W.R., Thomas, D.J., Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol. 12 (1999), 924–930.
39. Lin, S., Shi, Q., Nix, F.B., Styblo, M., Beck, M.A., Herbin-Davis, K.M., et al. A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol. J. Biol. Chem. 277 (2002), 10795–10803.
40. Liu, Q., Peng, H., Lu, X., Le, X.C., Enzyme-assisted extraction and liquid chromatography mass spectrometry for the determination of arsenic species in chicken meat. Anal. Chim. Acta 888 (2015), 1–9.
41. Liu, Q., Peng, H., Lu, X., Zuidhof, M.J., Li, X.F., Le, X.C., Arsenic species in chicken breast: temporal variations of metabolites, elimination kinetics, and residual concentrations. Environ. Health Perspect. 124:8 (2016), 1174–1181.
42. Mafla, S., Moraga, R., Leon, C.G., Guzman-Fierro, V.G., Yanez, J., Smith, C.T., et al. Biodegradation of roxarsone by a bacterial community of underground water and its toxic impact. World J. Microbiol. Biotechnol. 31:8 (2015), 1267–1277.
43. Mangalgiri, K.P., Adak, A., Blaney, L., Organoarsenicals in poultry litter: detection, fate, and toxicity. Environ. Int. 75 (2015), 68–80.
44. Maull, E.A., Ahsan, H., Edwards, J., Longnecker, M.P., Navas-Acien, A., Pi, J., et al. Evaluation of the association between arsenic and diabetes: a national toxicology program workshop review. Environ. Health Perspect. 120 (2012), 1658–1670.
45. Millar, I.T., Dimethyliodoarsine. Inorg. Synth. 6 (1960), 116–118.
46. Millar, I.T., Heaney, H., Heinecky, D.M., Fernelius, C., Methyldiiodoarsine. Inorg. Synth. 6 (1960), 113–115.
47. Moe, B., Yuan, C.G., Li, J.H., Du, H.Y., Gabos, S., Le, X.C., et al. Real-time cell-electronic sensing of coal fly ash particulate matter for toxicity-based air quality monitoring. Chem. Res. Toxicol. 29:6 (2016), 972–980.
48. Nachman, K.E., Baron, P.A., Raber, G., Francesconi, K.A., Navas-Acien, A., Love, D.C., Roxarsone, inorganic arsenic, and other arsenic species in chicken: a U.S.-based market basket sample. Environ. Health Perspect. 121 (2013), 818–824.
49. Naranmandura, H., Suzuki, N., Suzuki, K.T., Trivalent arsenicals are bound to proteins during reductive methylation. Chem. Res. Toxicol. 19 (2006), 1010–1018.
50. Naranmandura, H., Suzuki, N., Iwata, K., Hirano, S., Suzuki, K.T., Arsenic metabolism and thioarsenicals in hamsters and rats. Chem. Res. Toxicol. 20 (2007), 616–624.
51. Naranmandura, H., Ibata, K., Suzuki, K.T., Toxicity of dimethylmonothioarsinic acid toward human epidermoid carcinoma A431 cells. Chem. Res. Toxicol. 20 (2007), 1120–1125.
52. Naranmandura, H., Ogra, Y., Iwata, K., Lee, J., Suzuki, K.T., Weinfeld, M., et al. Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells. Toxicol. Appl. Pharmacol. 238 (2009), 133–140.
53. Naranmandura, H., Carew, M.W., Xu, S., Lee, J., Leslie, E.M., Weinfeld, M., et al. Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells. Chem. Res. Toxicol. 24 (2011), 1586–1596.
54. Naranmandura, H., Rehman, K., Le, X.C., Thomas, D.J., Formation of methylated oxyarsenicals and thioarsenicals in wild-type and arsenic (+ 3 oxidation state) methyltransferase knockout mice exposed to arsenate. Anal. Bioanal. Chem. 405 (2013), 1885–1891.
55. Nascimento, M.G., Suzuki, S., Wei, M., Tiwari, A., Arnold, L.L., Lu, X., et al. Cytotoxicity of combinations of arsenicals on rat urinary bladder urothelial cells in vitro. Toxicology 249 (2008), 69–74.
56. Naujokas, M.F., Anderson, B., Ahsan, H., Aposhian, H.V., Graziano, J.H., Thompson, C., et al. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ. Health Perspect. 121 (2013), 295–302.
57. NRC (National Research Council), Arsenic in Drinking Water. 1999, National Academies Press, Washington D.C.
58. NRC (National Research Council), Arsenic in Drinking Water: 2001 Update. 2001, National Academies Press, Washington, D.C.
59. Peng, H., Hu, B., Liu, Q., Yang, Z., Lu, X., Huang, R., et al. Liquid chromatography combined with atomic and molecular mass spectrometry for speciation of arsenic in chicken liver. J. Chromatogr. A 1370 (2014), 40–49.
60. Percy, A.J., Gailer, J., Methylated trivalent arsenic–glutathione complexes are more stable than their arsenite analog. Bioinorg. Chem. Appl., 539082, 2008.
61. III) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163 (2000), 203–207.
62. Pinyayev, T.S., Kohan, M.J., Herbin-Davis, K., Creed, J.T., Thomas, D.J., Preabsorptive metabolism of sodium arsenate by anaerobic microbiota of mouse cecum forms a variety of methylated and thiolated arsenicals. Chem. Res. Toxicol. 24 (2011), 475–477.
63. Raml, R., Rumpler, A., Goessler, W., Vahter, M., Li, L., Ochi, T., et al. Thio-dimethylarsinate is a common metabolite in urine samples from arsenic-exposed women in Bangladesh. Toxicol. Appl. Pharmacol. 222 (2007), 374–380.
64. Schuhmacher-Wolz, U., Dieter, H.H., Klein, D., Schneider, K., Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects. Crit. Rev. Toxicol. 39 (2009), 271–298.
65. 3) in the treatment of acute promyelocytic leukemia (APL). 2. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89:9 (1997), 3354–3360.
66. Solly, K., Wang, X., Xu, X., Strulovici, B., Zheng, W., Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev. Technol. 2 (2004), 363–372.
67. Styblo, M., Serves, S.V., Cullen, W.R., Thomas, D.J., Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10 (1997), 27–33.
68. Styblo, M., Del Razo, L.M., Vega, L., Germolec, D.R., LeCluyse, E.L., Hamilton, G.A., et al. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74 (2000), 289–299.
69. Styblo, M., Drobna, Z., Jaspers, I., Lin, S., Thomas, D.J., The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ. Health Perspect. 110:Suppl. 5 (2002), 767–771.
70. Sumi, D., Fukushima, K., Miyataka, H., Himeno, S., Alternative splicing variants of human arsenic (+ 3 oxidation state) methyltransferase. Biochem. Biophys. Res. Commun. 415 (2011), 48–53.
71. Sun, Y., Liu, G., Cai, Y., Thiolated arsenicals in arsenic metabolism: occurrence, formation, and biological implications. J. Environ. Sci. 49 (2016), 59–73.
72. Talbot, S., Nelson, R., Self, W.T., Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukemia. Br. J. Pharmacol. 154 (2008), 940–948.
73. Thomas, D.J., Styblo, M., Lin, S., The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176 (2001), 127–144.
74. Thomas, D.J., Waters, S.B., Styblo, M., Elucidating the pathway for arsenic methylation. Toxicol. Appl. Pharmacol. 198 (2004), 319–326.
75. Thomas, D.J., Li, J.X., Waters, S.B., Xing, W.B., Adair, B.M., Drobna, Z., et al. Arsenic (+ 3 oxidation state) methyltransferase and the methylation of arsenicals. Exp. Biol. Med. 232 (2007), 3–13.
76. Vahter, M., Mechanisms of arsenic biotransformation. Toxicology 181 (2002), 211–217.
77. Vega, L., Styblo, M., Patterson, R., Cullen, W., Wang, C., Germolec, D., Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 172 (2001), 225–232.
78. 2) mediated degradation of organoarsenic feed additive p-arsanilic acid. Environ. Sci. Technol. 49:6 (2015), 3473–3481.
79. Wang, Z., Zhou, J., Lu, X., Gong, Z., Le, X.C., Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Chem. Res. Toxicol. 17 (2004), 95–103.
80. Wang, Q.Q., Thomas, D.J., Naranmandura, H., Importance of being thiomethylated: formation, fate, and effects of methylated thioarsenicals. Chem. Res. Toxicol. 28 (2015), 281–289.
81. Xia, M., Huang, R., Witt, K.L., Southall, N., Fostel, J., Cho, M.H., et al. Compound cytotoxicity profiling using quantitative high-throughput screening. Environ. Health Perspect. 116 (2008), 284–291.
82. Xing, J.Z., Zhu, L., Jackson, J.A., Gabos, S., Sun, X.J., Wang, X.B., et al. Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem. Res. Toxicol. 18 (2005), 154–161.
83. Yao, L., Huang, L., He, Z., Zhou, C., Li, G., Occurrence of arsenic impurities in organoarsenics and animal feeds. J. Agric. Food Chem. 61 (2013), 320–324.
84. Yuan, H., Gong, Z., Yuan, I.Y., Han, B., Han, H.R., In vitro arsanilic acid induction of apoptosis in rat hepatocytes. Asian-Aust. J. Anim. Sci. 19:9 (2006), 1328–1334.
85. 2. Synth. Methods Organometal. Inorg. Chem. 3 (1996), 198–200.